Ads
related to: 23 & me genetic testingdnaweekly.com has been visited by 10K+ users in the past month
Search results
Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 3 days agoFree Report) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This quarterly report represents an earnings surprise of -8.33%. Over the ...
Her father's death fuels a lifelong push to understand South Asian heart health
San Francisco Chronicle· 17 hours agoDr. Latha Palaniappan, an internal medicine doctor and professor of cardiovascular medicine at...
Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger
Journal of the American Medical Association· 4 days agoThere has been a transformational change in understanding heart failure due to transthyretin cardiac amyloidosis (ATTR-CA). Previously considered a rare condition, the widespread adaptation ...
Her father's death fuels a lifelong push to understand South Asian heart health
Omaha World-Herald· 12 hours agoDr. Latha Palaniappan, an internal medicine doctor and professor of cardiovascular medicine at...
Myriad Genetics (NASDAQ:MYGN) Hits New 52-Week High at $24.92
ETF DAILY NEWS· 5 days agoMyriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $24.92 and last ...
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024
Seattle Times· 6 days agoStocks that are trading heavily or have substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall.
LIVE UPDATES | The latest from day 23 of the Chad Daybell murder trial - East Idaho News
EastIdahoNews.com· 2 days ago9:48 a.m. A number of digital devices were recovered and turned over to the FBI cellular analysis...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 7 days agoSales surged 23% to $506 million, topping analysts' $502.1 million projection, according to...
Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete
The News-Times· 2 days agoSubmission of a sample to a national donor program sparked an unexpected connection between a...
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $24.86 Consensus Target Price from Analysts
ETF DAILY NEWS· 2 days agoSVB Leerink raised shares of Myriad Genetics from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $25.00 to $35.00 ...
Ads
related to: 23 & me genetic testingdnaweekly.com has been visited by 10K+ users in the past month